These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
33 related articles for article (PubMed ID: 22920210)
21. Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis. Quinn GP; Vadaparampil ST; Bower B; Friedman S; Keefe DL Minerva Med; 2009 Oct; 100(5):371-83. PubMed ID: 19910890 [TBL] [Abstract][Full Text] [Related]
22. [Update on genetic predisposition to prostate cancer]. Cussenot O; Cancel-Tassin G Bull Cancer; 2015 Jan; 102(1):53-6. PubMed ID: 25609482 [TBL] [Abstract][Full Text] [Related]
23. "I do not want my baby to suffer as I did"; prenatal and preimplantation genetic diagnosis for BRCA1/2 mutations: a case report and genetic counseling considerations. Dagan E; Gershoni-Baruch R; Kurolap A; Goldberg Y; Fried G Genet Test Mol Biomarkers; 2014 Jul; 18(7):461-6. PubMed ID: 24915046 [TBL] [Abstract][Full Text] [Related]
24. BRCA-associated Cancers: Role of Imaging in Screening, Diagnosis, and Management. Lee MV; Katabathina VS; Bowerson ML; Mityul MI; Shetty AS; Elsayes KM; Balachandran A; Bhosale PR; McCullough AE; Menias CO Radiographics; 2017; 37(4):1005-1023. PubMed ID: 28548905 [TBL] [Abstract][Full Text] [Related]
29. [Genetic counselling in male carriers of BRCA1 and BRCA2 gene mutations]. Plevová P; Hladíková A Klin Onkol; 2012; 25 Suppl():S67-73. PubMed ID: 22920210 [TBL] [Abstract][Full Text] [Related]
30. Histology of prophylactically removed ovaries from BRCA1 and BRCA2 mutation carriers compared with noncarriers in hereditary breast ovarian cancer syndrome kindreds. Casey MJ; Bewtra C; Hoehne LL; Tatpati AD; Lynch HT; Watson P Gynecol Oncol; 2000 Sep; 78(3 Pt 1):278-87. PubMed ID: 10985881 [TBL] [Abstract][Full Text] [Related]
31. Counseling for male BRCA mutation carriers: a review. Mohamad HB; Apffelstaedt JP Breast; 2008 Oct; 17(5):441-50. PubMed ID: 18657973 [TBL] [Abstract][Full Text] [Related]
32. Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. Liede A; Karlan BY; Narod SA J Clin Oncol; 2004 Feb; 22(4):735-42. PubMed ID: 14966099 [TBL] [Abstract][Full Text] [Related]
33. [Molecular basis of breast cancer related to BRCA 1 and BRCA2 genes: characteristics and targeting therapy]. Levanat S; Cvok ML Lijec Vjesn; 2010; 132(1-2):34-7. PubMed ID: 20359158 [TBL] [Abstract][Full Text] [Related] [Previous] [New Search]